Anta Biotechnologies Corporation
San Diego, CA
- UEI
- U1B4HRNRXEM9
- CAGE
- 9JJL0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 9276 Scranton Rd #500, San Diego, CA 92121, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $174,499 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir 1AUTOMATED DNA extraction in space | Shared Services Center | $174,499 |
Grant awards
Similar vendors
About the company
Anyglabs, Inc. is a minority-owned, woman-owned, and Subcontinent Asian American-owned small business located in San Diego, California, specializing in advanced biotechnology solutions with a primary focus on developing innovative DNA extraction and sequencing technologies for space and austere environments. The company is registered in the System for Award Management (SAM.gov) and has demonstrated a strategic approach to developing cutting-edge scientific technologies that address complex challenges in molecular diagnostics and research.
Through its federal contract awards, Anyglabs, Inc. has secured a Small Business Innovation Research (SBIR) Phase I contract with a civilian federal agency for developing an "AUTOMATED DNA EXTRACTION IN SPACE" solution. The contract, valued at $174,499.00, is a firm-fixed-price definitive contract set aside for small businesses, with a performance period ending on March 27, 2026. The contract represents the company's capabilities in creating innovative scientific solutions specifically designed for challenging research environments, with a particular emphasis on space-related technological advancements.
Anyglabs, Inc. has been successful in obtaining federal grant awards from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program, specifically through SBIR Phase I and Phase II grants. These grants, totaling approximately $1.5 million, support the development of an autonomous, miniaturized system for DNA extraction and preparation for sequencing in space and austere environments. The grant projects aim to disrupt the global DNA sequencing market by creating a portable, automated solution for extracting DNA from various biosamples, with potential applications in medical research, environmental monitoring, and space exploration. The company's long-term vision includes generating nearly $20 million in revenue by the third year of production and democratizing access to advanced molecular diagnostic technologies.
Quick answers
Is Anta Biotechnologies Corporation registered in SAM.gov?
Yes. Anta Biotechnologies Corporation's SAM.gov registration is active through January 7, 2027.
How much has Anta Biotechnologies Corporation received in federal contracts?
Federal contracts obligated $174,499 to Anta Biotechnologies Corporation in fiscal year 2025.
What is Anta Biotechnologies Corporation's most recent federal award?
Anta Biotechnologies Corporation's most recent federal contract award is Sbir 1AUTOMATED DNA extraction in space (80NSSC25C0139), from Shared Services Center, on September 29, 2025.
On GovTribe
See Anta Biotechnologies Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors